EVALUATION OF THE ANTIDIABETIC ACTIVITY OF METHANOLIC EXTRACT OF COPTIS TRIFOLIA IN STREPTOZOTOCIN-INDUCED DIABETES RATS

Read full text Summarise with VIRAT
Authors: Jyoti Prakash Singh Santosh Kumar Panda*
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The present study aimed to evaluate the antidiabetic, hypolipidemic, and antioxidant activities of the methanolic extract of Coptis trifolia in a streptozotocin-induced hypertensive rat model. Rats were divided into five groups: normal control, Streptozotocin control, standard drug (hydrochlorothiazide), and two doses of Coptis trifolia extract (200 mg/kg and 500 mg/kg). Treatment was administered orally, and parameters including fasting blood glucose, serum insulin, lipid profile, liver glycogen content, antioxidant enzyme levels (GST, GSH, SOD), and body weight changes were measured. Streptozotocin treatment induced significant hyperglycemia, dyslipidemia, oxidative stress, and weight loss. Administration of Coptis trifolia extract significantly reduced fasting blood glucose and improved glucose tolerance, serum insulin levels, and liver glycogen content in a dose-dependent manner. Additionally, the extract normalised serum lipid profiles by lowering total cholesterol, triglycerides, LDL-C, and VLDL-C, while increasing HDL-C. Antioxidant enzyme activities and total protein content were markedly restored by Coptis trifolia treatment, indicating a potent antioxidative effect. The Coptis trifolia methanolic extract exerts multi-faceted protective effects against metabolic disturbances associated with Streptozotocin induced hypertension. This supports its potential therapeutic application as a natural agent for managing diabetes and cardiovascular complications. Keywords: Coptis trifolia , hypertension, hypertension, LDL-C, cholesterols

Fields of Study & Subjects

Natural Antidiabetic Agents Studies Medicinal Plant Research Berberine and alkaloids research

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
30 March 2026
Language
EN